Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Daniele J. Perrault"'
Autor:
Joseph L. Pater, Kathleen I. Pritchard, Daniele J. Perrault, Elizabeth Eisenhauer, Shailendra Verma
Publikováno v:
Investigational New Drugs. 8:283-287
We have carried out a phase II study of intravenous menogaril given every four weeks in a group of patients with breast cancer who had received no prior chemotherapy for metastatic disease. Myelosuppression, nausea and vomiting and local reactions we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b70dbc84a719779c7ad621bafbfe1822
https://doi.org/10.1007/bf00171838
https://doi.org/10.1007/bf00171838
Autor:
Sunil Gupta, Vincent Young, Daniele J. Perrault, David J. Stewart, Lucille Robillard, Betty Fontaine, Jean A. Maroun, Shailendra Verma
Publikováno v:
Investigational New Drugs. 8:275-281
Twenty-one adult patients with refractory solid tumors were treated on a phase I study of idarubicin (4-demethoxydaunorubicin) administered daily for 3 days every 3 weeks. Nineteen of the patients had received previous chemotherapy (including 13 with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::624266f9629133584e999d7a3127c128
https://doi.org/10.1007/bf00171837
https://doi.org/10.1007/bf00171837
Autor:
Daniele J. Perrault, David J. Stewart, Vivien H.C. Bramwell, Alexander H. G. Paterson, Elizabeth Eisenhauer, D. Logan
Publikováno v:
Investigational New Drugs. 6:207-210
The National Cancer Institute of Canada (NCIC) Clinical Trials Group conducted a phase II study of the oral antiandrogen flutamide in 33 patients with metastatic breast cancer. Eight patients had received no prior systemic therapy for their metastati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8661a4bec117e1048f734e5943e87f0b
https://doi.org/10.1007/bf00175399
https://doi.org/10.1007/bf00175399
Publikováno v:
American Journal of Clinical Oncology. 12:511-518
Thirty-nine adults with solid tumors were treated on a Phase I study of menogaril administered i.v. once each week. Granulocytopenia was dose-limiting at a menogaril dose of 115 mg/m2/wk. Ten patients required delays in treatment of 1-4 weeks (median
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a31b5c66f07347d36ce3e26d33972ce5
https://doi.org/10.1097/00000421-198912000-00011
https://doi.org/10.1097/00000421-198912000-00011
Autor:
Charles Erlichman, H Sutherland, Ian F. Tannock, Gerrit DeBoer, S. Fine, C Mayers, G Larocque, Daniele J. Perrault, Norman F. Boyd
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 6(9)
This study was designed to assess the role of dosage of chemotherapy for treatment of metastatic breast cancer. One hundred thirty-three patients without prior chemotherapy for metastatic disease were randomly allocated to receive two different dose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fb0704e086134ce90946ab49b6e0bdc
https://pubmed.ncbi.nlm.nih.gov/2918336
https://pubmed.ncbi.nlm.nih.gov/2918336
Autor:
J. William Meakin, Roy M. Clark, Kathleen I. Pritchard, Donald J.A. Sutherland, Daniele J. Perrault, S. Fine
Publikováno v:
Annals of internal medicine. 89(3)
Excerpt To the editor: To prove that tamoxifen causes hypercalcemia in advanced breast cancer, as has been suggested by Veldhuis (1) and others (2-4), would require that three criteria be met. The ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6da07ff3aed379c553ee49dbd9c625e0
https://pubmed.ncbi.nlm.nih.gov/686559
https://pubmed.ncbi.nlm.nih.gov/686559
Autor:
David Bowman, Vivien H.C. Bramwell, Nancy Paul, H. Abu-Zahra, Margaret A. Knowling, Joseph Ragaz, David Warr, Lois E. Shepherd, Mate Poljicak, Harold Weizel, Kathleen I. Pritchard, Alexander H.G. Paterson, Benny Zee, S. Fine, Mark Levine, P. L. Walde, B. Norris, S. Verma, Robert Buckman, George R. Armitage, Daniele J. Perrault, Norman F. Boyd
Publikováno v:
Scopus-Elsevier
Europe PubMed Central
Europe PubMed Central
PURPOSE AND METHODS By the mid 1980s, tamoxifen alone was considered standard adjuvant therapy for postmenopausal women with node-positive, estrogen receptor (ER)- or progesterone receptor (PgR)-positive breast cancer. From 1984 through 1990, 705 eli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fd6bd8c0754006dcb7d98bf5d99be7f
http://www.scopus.com/inward/record.url?eid=2-s2.0-0030979449&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0030979449&partnerID=MN8TOARS
Autor:
Edward Domovitch, Daniele J. Perrault
Publikováno v:
Annals of Internal Medicine. 100:160
Excerpt To the editor: We wish to report a second case of aminoglutethimide hypersensitivity associated with cholestatic jaundice (1). On 16 February, a 69-year-old woman with bony, pleural and sof...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5cdbdd9528fb6f909e1e6bd89388ae4
https://doi.org/10.7326/0003-4819-100-1-160_1
https://doi.org/10.7326/0003-4819-100-1-160_1